Ampac Fine Chemicals will use Codexis' proprietary biocatalysis technology to develop lower cost, more efficient and lower environmental impact processes for pharmaceutical intermediates and APIs.
PR Newswire
Monday 29 March 2010
Ampac confirms manufacturing deal with Codexis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment